Mircera (Methoxy Polyethylene glycol-epoetin beta) Drug Center: Guide to Drug Information for Professionals, Patients and Caregivers at RxList

Pill Identifier Search

May 27, 2012

« Previous
1
2
3
4
5
6
7
8
9
10
Next »

Mircera

Breast Cancer Slideshow Pictures

Pancreatic Cancer Slideshow Pictures

Skin Cancer Slideshow Pictures

font size

Mircera Drug Center

What is Prescribing information?

The FDA package insert formatted in easy-to-find categories for health professionals and clinicians.

Mircera Prescribing Information: Indications & Dosage

Mircera (methoxy polyethylene glycol-epoetin beta) is indicated for the treatment of anemia associated with chronic renal failure (CRF) in adults, including patients on dialysis and not on dialysis.

Mircera (methoxy polyethylene glycol-epoetin beta) is not indicated for the treatment of anemia due to cancer chemotherapy [see Warnings and PRECAUTIONS].

Read the complete drug monograph for Mircera »

What is Mircera Prescribing Information?

Drug Description - Indications & Dosage - Side Effects & Drug Interactions - Warnings & Precautions - Contraindications - Medication Guide and More

What is Patient information?

Easy-to-read and understand detailed drug information and pill images for the patient or caregiver from Cerner Multum.

Mircera Patient Information: Side Effects

Contact your doctor if you feel weak, tired, or short of breath, or if your skin looks pale. These may be signs that your body has stopped responding to this medication.

Epoetin beta-methoxy polyethylene glycol can increase your risk of life-threatening heart or circulation problems, including heart attack or stroke. Seek emergency medical help if you have symptoms of heart or circulation problems, such as:

chest pain or heavy feeling, pain spreading to the arm or shoulder, nausea, sweating, general ill feeling;
feeling short of breath, even with mild e...

Read the complete patient information for Mircera »